Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,000
Closed -$74.6K 63
2023
Q1
$74.6K Hold
10,000
0.01% 59
2022
Q4
$124K Hold
10,000
0.01% 66
2022
Q3
$206K Hold
10,000
0.02% 69
2022
Q2
$277K Buy
+10,000
New +$342K 0.02% 73

Other funds holding AFMD

WS Management's AFMD Position: Q2 2023 in Review

WS Management sold out of Affimed (AFMD) in Q2 2023, closing a stake of 10,000 shares — an estimated $74.6K sold.

WS Management first reported a position in AFMD in Q2 2022 and held it in 4 quarters. The position peaked at $277K in Q2 2022. 80 funds tracked by Wall St. Rank hold AFMD as of Q2 2023.

  • WS Management reported no remaining Affimed position as of Q2 2023 after selling out during the quarter.
  • WS Management sold 10,000 Affimed shares in Q2 2023, an estimated $74.6K.
  • WS Management first reported a position in Affimed in Q2 2022 and held it in 4 quarters.
  • WS Management's Affimed position peaked at $277K in Q2 2022.
  • 80 funds tracked by Wall St. Rank held Affimed as of Q2 2023.

Based on WS Management's 13F filing for Q2 2023, filed 10 Aug 2023.